Abstract
Trimester specific reference ranges of hematological indices were described in several populations; however, comparable reports among Sudanese women with normal pregnancy are lacking. To evaluate trimester pattern of change and reference ranges of hematological profile among Sudanese women with normal pregnancy, we followed 143 women with singleton gestation since early pregnancy until the third trimester in Saad Abu-Alela Hospital, Khartoum, Sudan, during the period of January-December 2015. Obstetrics and medical history was gathered using questionnaire and hematological profile was investigated using hemo-analyser. The first, second and third trimester mean (SD) [5th-95th centile] of hematological profile were as follow: RBC counts 4.30 (0.36) [3.69-4.93], 4.35 (0.36) [3.69-4.93], 4.08 (0.44) [3.44-4.78] ×106/mm3; hemoglobin concentration 10.81 (1.22) [8.92-12.74], 10.62 (0.93) [9.00-12.10], 10.83 (1.13) [8.82-12.60] g/dL; hematocrit 35.38 (3.52) [30.12-40.30], 34.43 (2.51) [30.58-38.23], 35.17 (3.18) 29.66-40.04] %; WBC counts 7.69 (1.96) [4.36-11.20], 8.45 (1.97) [5.48-12.13], 8.36 (2.11) [5.00-11.96] ×103/mm3; platelet counts 278.02 (66.93) [182.6-418.0], 251.96 (64.17) [163.8-381.8], 238.36 (57.10) [150.4-346.2] ×103/mm3. The present study is the first to establish trimester specific, reference range for hematological profile among Sudanese women with normal pregnancy. The trimester reference range of RBC, WBC and platelets and other hematological indices are mostly parallel to international records.
Key words: Hematological profile, pregnancy, reference range, Sudan, trimester
Competing interest statement
Conflict of interest: the authors declare no potential conflict of interest.
Introduction
Regular assessment of hematological profile during pregnancy is an essential practice in antenatal care clinics.1 Hematological profile can reflect nutritional, immunological, hemostatic status of the pregnant women.2 Likewise, it is an important predictor of pregnancy outcomes.3 Physiologically, activation of renin-angiotensin-aldosterone system during pregnancy increases extracellular fluid4 and consequently plasma volume.5 Maternal erythropoiesis,6 neutrophil apoptosis,7 platelet activation and clearance8 are enhanced during pregnancy. The hematocrit (HCT), plateletcrit (PCT), counts of red blood corpuscles (RBC), white blood corpuscles (WBC) and platelets (PLT) are expected to change according to the degree of plasma volume expansion4,5 and the amount of blood formed elements being added6 or removed7,8 from the circulation. Release of young RBC and activation of platelets affect the readings of some hematological indices like mean corpuscular volume (MCV), red cell distribution width (RDW), mean platelet volume (MPV) and platelet distribution width (PDW).2,8 However, the exact pattern of trimester change of these hematological indices, and others, remained ill-defined. This fact encouraged researchers in the field to investigate for trimester specific, reference range for hematological profile during normal pregnancy.9-14 Studies assessing detailed hematological profile during normal pregnancy are scarce before invention of automated hematology analyzer. Over the last decade, trimester specific reference ranges of hematological indices were reported in several western,11 eastern12,13 and African populations.10,14 We could not find a report exploring hematological profile among Sudanese women with normal pregnancy, a part from a study exploring physiological variations of blood formed elements counts in 50 healthy pregnant Sudanese women.9 The present study aimed to evaluate trimester pattern of change and reference ranges of fifteen important hematological parameters among Sudanese women with normal pregnancy. We believed that the findings of this study would help in precise interpretation of laboratory results, correct diagnosis and appropriate management of blood disorders among pregnant Sudanese women.
Materials and Methods
A longitudinal study was conducted at the antennal care clinics of Saad Abu-Alela Hospital (Khartoum, Sudan) during the period of January-December 2015. Women with singleton pregnancy were enrolled since early gestation and followed till the third trimester. After signing an informed consent, questionnaires were used to gather the medical and obstetrics history (age, parity, gravidity, gestational age). Pregnancy and its duration were confirmed by ultrasound. Women with thyroid disease, hypertension, renal disease, diabetes, liver disease and on medication(s) were excluded from the study.
During each visit the blood pressure was measured using a sphygmomanometer. The weight and height measured during the first visit were used to calculate the body mass index (BMI), which was expressed as weight (kg)/height2 (m2). During each visit, 2 mL of blood was taken from every women in an ethylene diamine tetra acetic acid, analyzed immediately for a complete hemogram using an automated hematology analyzer and following the manufacturers’ instructions as previously described.15,16 Combined tablets of iron and folic acid were prescribed to every woman.
A total sample size of 140 women was calculated using a formula for longitudinal study and the difference in the mean of the proposed variables (mainly hemoglobin, WBC and platelets) that would provide 80% power to detect a 5% difference at α = 0.05, and assumed that 10% of women will be lost during follow-up or will not respond.
Statistics
Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) for Windows, version 16.0 (SPSS Inc., Chicago, IL, USA). Proportions of the studied groups were expressed in percentages (%). Means (M) and standard deviations (SD) were used to describe the studied variables. 5th-95th centiles were used to identify reference ranges of hematological profile among Sudanese women with normal pregnancy. The repeated measure ANOVA and LSD Post hoc analyses were used to evaluate the differences in the means of the hematological indices between different trimesters. P<0.05 was considered significant.
Ethics
Ethical clearance was obtained from the Department of Obstetrics and Genecology, Faculty of Medicine, University of Khartoum. Written informed consent was provided by each volunteer before being enrolled in the study.
Results
Out of 175 pregnant women who were enrolled initially, 143 (81.7%) completed the follow-up till the third trimester. The rest (18.3%) were lost during follow-up due to address change. The mean age of the pregnant women enrolled in the study (N = 143) was 27.94±5.45 years (range 18-42 years). The other obstetric and socio-demographic characteristics of the studied pregnant women are summarized in Table 1.
Table 1.
Characteristics of the studied pregnant women (N = 143).
| M (SD) N (%) |
|
|---|---|
| Age (years) | 27.94 (5.45) |
| Gravidity | 2.62 (2.96) |
| Parity | 1.06 (1.24) |
| Inter-pregnancy interval (months) | 20.36 (25.52) |
| History of miscarriage | 0.26 (0.42) |
| History of stillbirth | 0.03 (0.17) |
| First visit BMI (kg/m2) | 27.89 (6.08) |
| First visit SBP (mmhg) | 109.30 (10.12) |
| First visit DBP (mmhg) | 71.75 (5.88) |
| Urban residence | 124 (86.71) |
| University or higher education | 124 (86.71) |
| Housewife (non-employee) | 107 (4.83) |
Table 2 shows the M (SD) [5th-95th centiles] of RBC indices in the studied pregnant women. RBCs counts were comparable in the first and second trimester (4.30±0.36 vs 4.35±3.03 ×106/mm3, P=0.836), but decreased significantly during the third trimester (4.08±0.44×106/mm3, P < 0.001). In comparison, hematocrit was lower in the second trimester (34.43±2.51 %) compared with the first (35.38±3.52 %, P<0.003) as well as the third trimesters (35.17±3.18 %, P<0.008). MCV increased steadily throughout pregnancy while MCH and HCHC were higher during the last two thirds of pregnancy compared with the first trimester. RDW was lower during the third trimester (13.82±1.72%) compared with the first (13.99±1.76%) and the second (14.33±2.31 %) trimesters.
Table 2.
Mean (SD) [5th-95th centile] of RBC indices during pregnancy in Sudanese women.
| Variables | T1 | T2 | T3 | P |
|---|---|---|---|---|
| 10.92 (3.37) Weeks | 20.64 (3.94) Weeks | 31.12 (3.19) Weeks | ||
| RBC (x106/mm3) | 4.30 (0.36) | 4.35 (0.36) | 4.08 (0.44) | Inter-Trimesters < 0.001 |
| [3.69 4.93] | [3.69 4.93] | [3.44 4.78] | T1 vs T2 < 0.001 T1 vs T3 < 0.001 T2 vs T3 = 0.950 |
|
| HB (g/dl) | 10.81 (1.22) | 10.62 (0.93) | 10.83 (1.13) | Inter-Trimesters = 0.047 |
| [8.92 12.74] | [9.00 12.10] | [8.82 12.60] | T1 vs T2 = 0.154 T1 vs T3 =0.757 T2 vs T3 = 0.049 |
|
| HCT (%) | 35.38 (3.52) | 34.43 (2.51) | 35.17 (3.18) | Inter-Trimesters = 0.001 |
| [30.12 40.30] | [30.58 38.23] | [29.66 40.04] | T1 vs T2 = 0.003 T1 vs T3 = 0.591 T2 vs T3 = 0.008 |
|
| MCV (fL) | 82.68 (7.64) | 85.16 (6.99) | 86.40 (6.51) | Inter-Trimesters < 0.001 |
| [65.50 93.02] | 71.35 94.70] | [73.40 95.68] | T1 vs T2 < 0.001 T1 vs T3 < 0.001 T2 vs T3 = 0.001 |
|
| MCH (pg) | 25.16 (2.78) | 26.68 (5.84) | 26.57 (2.56) | Inter-Trimesters < 0.001 |
| [19.40 28.74] | [20.83 30.15] | [21.34 30.18] | T1 vs T2 = 0.002 T1 vs T3 < 0.001 T2 vs T3 = 0.873 |
|
| MCHC (g/dL) | 30.45 (1.19) | 30.80 (1.16) | 30.73 (1.13) | Inter-Trimesters = 0.001 |
| [28.54 32.30] | [28.78 32.40] | [28.82 32.50] | T1 vs T2 < 0.001 T1 vs T3 = 0.008 T2 vs T3 = 0.617 |
|
| RDW (%) | 13.99 (1.76) | 14.33 (2.31) | 13.82 (1.72) | Inter-Trimesters = 0.061 |
| [12.00 17.94] | [12.40 18.81] | [12.11 17.50] | T1 vs T2 = 0.076 T1 vs T3 = 0.170 T2 vs T3 = 0.019 |
Table 3 shows the M (SD) [5th-95th centiles] of the total and differential WBC counts in the studied pregnant women. The total WBCs counts were lower during first trimester (7.69±1.96×106/mm3) compared with the last two thirds of pregnancy (8.45±1.97×06/mm3, P<0.001; 8.36±2.11 ×106/mm3, P = 0.002). Lymphocyte count was least during the third trimester; however, the count of other types of leukocytes remained comparable throughout pregnancy. Table 4 shows the M (SD) [5th-95th centiles] of platelets indices in the studied pregnant women. The platelets count and PCT decreased steadily while MPV remained with no significant change as pregnancy progress. PDW decreased significantly in the second compared with the first trimester (15.57±0.37 vs 15.68±0.36 %, P=0.002), but remained with no significant change thereafter.
Table 3.
Mean (SD) [5th-95th centile] of the total and differential WBC counts during pregnancy in Sudanese women.
| Variables | T1 | T2 | T3 | P |
|---|---|---|---|---|
| 10.92 (3.37) Weeks | 20.64 (3.94) Weeks | 31.12 (3.19) Weeks | ||
| WBC (x103/mm3) | 7.69 (1.96) | 8.45 (1.97) | 8.36 (2.11) | Inter-Trimesters < 0.001 |
| [4.36-11.20] | [5.48-12.13] | [5.00-11.96] | T1 vs T2 < 0.001 T1 vs T3 = 0.002 T2 vs T3 = 0.677 |
|
| GRAN (x103/mm3) | 6.54 (10.14) | 7.07 (8.95) | 5.89 (1.87) | Inter-Trimesters = 0.256 |
| [2.56-8.68] | [3.62-9.80] | [3.22-9.30] | T1 vs T2 = 0.959 T1 vs T3 = 0.312 T2 vs T3 = 0.177 |
|
| LYM (x103/mm3) | 2.20 (1.32) | 1.98 (0.45) | 1.87 (0.48) | Inter-Trimesters = 004 |
| [1.20-2.98] | [1.28-2.63] | [1.10-2.60] | T1 vs T2 = 0.082 T1 vs T3 = 0.011 T2 vs T3 = 0.009 |
|
| MID (x103/mm3) | 0.58 (0.21) | 0.65 (0.63) | 0.63 (0.33) | Inter-Trimesters = 0.397 |
| [0.30-0.99] | [0.30-0.90] | [0.30-1.00] | T1 vs T2 = 0.220 T1 vs T3 = 0.344 T2 vs T3 = 0.365 |
Table 4.
Mean (SD) [5th-95th centile] of platelets indices during pregnancy in Sudanese women.
| Variables | T1 | T2 | T3 | P |
|---|---|---|---|---|
| 10.92 (3.37) Weeks | 20.64 (3.94) Weeks | 31.12 (3.19) Weeks | ||
| Platelet (x103/mm3) | 278.02 (66.93) | 251.96 (64.17) | 238.36 (57.10) | Inter-Trimesters < 0.001 |
| [182.6-418.0] | [163.8-381.8] | [150.4-346.2] | T1 vs T2 < 0.001 T1 vs T3 < 0.001 T2 vs T3 = 0.016 |
|
| MPV (fL) | 8.13 (0.84) | 8.10 (0.87) | 8.19 (0.87) | Inter-Trimesters = 0.627 |
| [6.90-9.78] | [6.96-9.62] | [7.00-9.80] | T1 vs T2 = 0.772 T1 vs T3 = 0.490 T2 vs T3 = 0.333 |
|
| PDW (%) | 15.57 (0.37) | 15.68 (0.36) | 16.90 (12.40) | Inter-Trimesters = 0.003 |
| [15.10-16.29] | [15.20-16.30] | [15.40-16.60] | T1 vs T2 = 0.002 T1 vs T3 = 0.226 T2 vs T3 = 0.257 |
|
| PCT (%) | 0.24 (0.24) | 0.20 (0.05) | 0.20 (0.04) | Inter-Trimesters = 0.011 |
| [0.16-0.32] | [0.14-0.29] | [0.14-0.27] | T1 vs T2 = 0.054 T1 vs T3 = 0.026 T2 vs T3 = 0.020 |
Discussion
It is evident from the current results that maximum decrease in RBCs count was in the third trimester. In comparison, lowest HB and HCT as well as highest MCV, MCH, MCHC and RDW readings were achieved in the second trimester. Gradual decrement in RBCs count with progression of pregnancy was reported in a Sudanese study9 and several previous reports10-12 but not others.13 Similar to the present results, lowest means of HB and HCT were noted in the second trimester in at two separate Jamaican11 and Chinese12 studies. Assessment of 274 pregnant women attending Lagos University Teaching Hospital in Nigeria revealed comparable trimester peak of HCT to present results; however, HB concentration showed progressive decline from the first to the third trimester.14 According to the same study, maximum dipping of MHC and MCV were in the second and third trimesters respectively. In another Nigerian study, RBCs count and HB concentration decreased steadily throughout pregnancy, HCT underwent marked drop in the second trimester and remained unchanged thereafter.10 The maximum MCV was in the second trimester while MCH continued to rise up to the end of pregnancy.10 As shown in Table 5,10-13 the M (SD) of RBCs derived hematological parameters in the present study are comparable with international reports11-13 with only few exceptions.10 The average HB concentration and HCT reported by Akingbola et al., among Nigerian pregnant women10 were markedly lower compared with our results as well as international records.11-13 Likewise, the drop in HB concentration and HCT in the first trimester [11.24 (10.41) g/dL and 29.36 (4.22) respectively] compared to the third trimester [9.81 (1.32) g/dL and 29.36 (4.22) % respectively] were more than expected. Such significant drop in HB concentration and HCT between first and third trimesters is difficult to explain on physiological basis and suggest an etiology other than the normal hematological response to pregnancy.17,18
Table 5.
Comparison of trimester specific mean (SD) of hematological profile between the present study and previous international reports.
| Sudan | Nigeria10 | India13 | Jamaica11 | China12 | ||
|---|---|---|---|---|---|---|
| RBC (x106/mm3) | T1 | 4.30 (0.36) | 3.99 (0.56) | 4.00 (0.42) | 4.33 (0.40) | 4.05 (0.36) |
| T2 | 4.35 (0.36) | 3.42 (0.61) | 4.07 (0.24) | 3.80 (0.33) | 3.66 (0.33) | |
| T3 | 4.08 (0.44) | 3.31 (0.59) | 4.16 (1.83) | 3.94 (0.36) | 3.79 (0.36) | |
| HB (g/dl) | T1 | 10.81 (1.22) | 11.24 (1.04) | 10.48 (0.89) | 12.73 (1.14) | 12.20 (0.92) |
| T2 | 10.62 (0.93) | 10.03 (1.41) | 10.06 (1.04) | 11.41 (1.16) | 11.30 (0.89) | |
| T3 | 10.83 (1.13) | 9.81 (1.32) | 10.02 (1.26) | 11.67 (1.18) | 11.50 (0.99) | |
| HCT (%) | T1 | 35.38 (3.52) | 35.20 (3.74) | 37.51 (2.60) | 37.05 (2.96) | 36.0 (2.55) |
| T2 | 34.43 (2.51) | 29.34 (4.42) | 32.88 (2.96) | 33.12 (3.00) | 34.0 (2.30) | |
| T3 | 35.17 (3.18) | 29.36 (4.22) | 33.7 (3.27) | 34.03 (2.97) | 35.0 (2.81) | |
| MCV (fL) | T1 | 82.68 (7.64) | 82.67 (4.09) | 81.86 (7.43) | 85.89 (7.28) | 90.30 (4.06) |
| T2 | 85.16 (6.99) | 84.55 (6.24) | 82.89 (8.35) | 87.49 (7.02) | 93.40 (4.72) | |
| T3 | 86.40 (6.51) | 84.36 (6.14) | 85.69 (13.9) | 86.70 (6.85) | 93.20 (5.48) | |
| MCH (pg) | T1 | 25.16 (2.78) | 28.29 (1.90) | 26.15 (2.86) | 29.53 (2.92) | 30.60 (1.43) |
| T2 | 26.68 (5.84) | 29.71 (3.12) | 26.96 (3.31) | 30.15 (3.01) | 31.20 (1.81) | |
| T3 | 26.57 (2.56) | 31.37 (2.92) | 27.31 (2.54) | 29.85 (3.13) | 31.00 (2.04) | |
| MCHC (g/dL) | T1 | 30.45 (1.19) | 34.20 (1.16) | 31.49 (2.87) | 34.35 (1.05) | 33.80 (0.82) |
| T2 | 30.80 (1.16) | 35.10 (2.10) | 32.99 (1.97) | 34.42 (1.30) | 33.30 (1.02) | |
| T3 | 30.73 (1.13) | 35.30 (2.50) | 30.47 (6.65) | 34.33 (1.43) | 33.00 (1.07) | |
| RDW (%) | T1 | 13.99 (1.76) | 12.74 (1.93) | 14.07 (1.01) | - | - |
| T2 | 14.33 (2.31) | 12.56 (1.23) | 15.07 (2.43) | - | - | |
| T3 | 13.82 (1.72) | 12.82 (1.32) | 18.9 (3.85) | - | - | |
| WBC (x103/mm3) | T1 | 7.69 (1.96) | 5.49 (1.75) | 7.85 (1.41) | 8.27 (2.60) | 8.30 (2.02) |
| T2 | 8.45 (1.97) | 6.61 (2.13) | 9.70 (2.43) | 9.66 (2.84) | 9.50 (2.22) | |
| T3 | 8.36 (2.11) | 6.80 (2.27) | 10.17 (1.14) | 8.79 (2.50) | 9.10 (2.17) | |
| GRAN (x103/mm3) | T1 | 6.54 (10.14) | 3.71 (1.74) | - | - | - |
| T2 | 7.07 (8.95) | 4.19 (1.78) | - | - | - | |
| T3 | 5.89 (1.87) | 4.39 (1.74) | - | - | - | |
| LYM (x103/mm3) | T1 | 2.20 (1.32) | 1.93 (0.70) | - | - | - |
| T2 | 1.98 (0.45) | 1.87 (0.61) | - | - | - | |
| T3 | 1.87 (0.48) | 1.95 (0.87) | - | - | - | |
| MID (x103/mm3) | T1 | 0.58 (0.21) | 0.44 (0.20) | - | - | - |
| T2 | 0.65 (0.63) | 0.49 (0.24) | - | - | - | |
| T3 | 0.63 (0.33) | 0.48 (0.31) | - | - | - | |
| Platelet (x103/mm3) | T1 | 278.0 (66.9) | 227.5 (81.11) | 333.0 (63.0) | 280.55 (64.40) | 164.0 (50.77) |
| T2 | 252.0 (64.2) | 229.5 (98.34) | 312.0 (39.9) | 250.32 (67.95) | 155.0 (46.94) | |
| T3 | 238.4 (57.1) | 186.5 (60.22) | 254.0 (43.0) | 234.15 (67.67) | 150.0 (45.15) | |
| MPV (fL) | T1 | 8.13 (0.84) | 8.09 (0.88) | - | - | - |
| T2 | 8.10 (0.87) | 7.90 (0.88) | - | - | - | |
| T3 | 8.19 (0.87) | 7.88 (0.87) | - | - | - | |
| PDW (%) | T1 | 15.57 (0.37) | 14.08 (2.60) | - | - | - |
| T2 | 15.68 (0.36) | 16.08 (2.19) | - | - | - | |
| T3 | 16.90 (12.40) | 16.12 (1.96) | - | - | - | |
| PCT (%) | T1 | 0.24 (0.24) | 0.18 (0.06) | - | - | - |
| T2 | 0.20 (0.05) | 0.18 (0.07) | - | - | - | |
| T3 | 0.20 (0.04) | 0.15 (0.05) | - | - | - |
Physiologically, increased vascular capacity secondary to systemic vasodilatation stimulates renin-angiotensin-aldosterone system, which explains blood volume expansion during pregnancy.4 Based on Evans blue dye dilution methods, at least 10-15 % increment in plasma volume occurs at the start of the second trimester.5 Maternal erythropoiesis is also enhanced during pregnancy; however, the increase RBC count (18-25%) is usually less compared with the ultimate expansion of plasma volume (50%).6 The resulted dilutional anemia causes significant drop in RBCs count, HB and HCT during the second trimester, which remains unchanged thereafter in the third trimester.8 Absence of further drop over the third trimester is probably due to high levels of atrial natriuretic peptide and consequently contraction in maternal plasma volume.8 Enhanced maternal erythropoiesis during pregnancy results in release of more young erythrocytes to the circulation, which are usually larger in size compared with the mature RBCs. High young erythrocytes count explains the steady increment of MCV throughout pregnancy. A longitudinal study among women with normal pregnancy demonstrated no variations in RDW between 16 and 34 weeks but significant increase afterward, up to the onset of labor.19 The unpredicted increase in the RDW over the 4-6 weeks before the onset of labor points to enhanced bone marrow activity; however, stimulus for this remained unexplained. Noteworthy, the physiological changes in RBCs count, HB, HCT, MCV and RDW during pregnancy are further modified by nutritional,20 medical and obstetric complications,21 which explains trimester variations of hematological profile described in previous studies.9-14
The current results showed significant rise in the total WBC count during the last two thirds of pregnancy compared with first trimester. Lymphocytes counts followed reverse pattern of change, being comparable during the first two trimesters but dropped significantly over the last one. In contrast, the counts of GRAN and MID were comparable throughout the three trimesters. The relatively increased total WBC count demonstrated in the current results is supported by several previous reports.11-13 According to local9 and international studies,11-13 total WBC count is hardly less than 7000/mm3 during pregnancy (Table 4). The exact cause of relative leukocytosis during gestation is yet to be explored by further researches; however, physical and emotional stress associated with pregnancy22 and depressed neutrophil apoptosis7 could be possible causes. Similar to the present findings, Kühnert et al., demonstrated slight elevation of lymphocytes count at the start pregnancy but gradual decrease over the following trimesters.23 In a longitudinal study, Pitkin et al. attributed the rise in total WBC count to synonymous increase in the number of neutrophils.24 Regarding other types of leukocytes, the study showed increased monocyte and decreased lymphocytes, eosinophils, and basophils as pregnancy advanced.24 Another report confirmed monocytosis during pregnancy, but denied significant rise in eosinophil and basophil counts,8 which disagreed with Pitkin et al. implications.
The present data showed steady decrease of platelets count and PCT, increase of PDW and unchanged MPV as pregnancy progress. Decreased platelets count and PCT were repeatedly demonstrated during normal pregnancy.10-13,25 Thrombocytopenia during pregnancy was attributed to plasma volume expansion, enhanced platelet activation and clearance.8 Theoretically, hemodilution and platelet activation associated with pregnancy can induce platelets swelling, pseudopodia formation and hence increase MPV and PDW. According to one study, PDW displayed substantial increase from the first to the third trimester of pregnancy; however, MPV failed to show the same trend.26 Noteworthy, comparable trimester changes of MPV and PDW were reproduced by the present study and others.10 The preferential rise PDW, but not MPV, as pregnancy advances suggests that variations in platelets size during gestation are principally due to platelet activation rather than hemodilution.26
Noteworthy, this study enrolled pregnant women with regular antenatal follow-up. Studied women received proper medical advice, regular checkup investigations and hematinic. The hematological reference range derived from the present study would be helpful in evaluating pregnant women with healthcare, socioeconomic and racial background comparable to our participants. However, a potential limitation remained because our results could not uncover pattern of trimester change in hematological profile of pregnant women with inadequate antenatal care. Another limitation of the study is the lack of controls for hematological profile readings (preconception or 6-weeks postpartum).
Conclusions
The present study is the first to establish detailed, trimester specific, reference range for hematological profile among Sudanese women with normal pregnancy. The reference range of RBC, WBC and platelets indices are mostly parallel to international records. The trimester pattern of change of hematological profile among Sudanese is comparable with previous reports in this regard. The plasma volume expansion, physiological stress associated with pregnancy and preferential increased hematopoiesis of some blood formed elements, but not others, seemed to be the main grounds for hematological profile changes during pregnancy.
Acknowledgments
We would like to thank patients in Saad Abu-Alela Hospital, Khartoum, Sudan, for their assistance with obtaining the data used in this study.
References
- 1.Gedefaw L, Ayele A, Asres Y, et al. Anemia and associated factors among pregnant women attending antenatal care clinic in Wolayita Sodo Town, Southern Ethiopia. Ethiopian J Health Sci 2015;25:155-62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Townsley DM. Hematologic complications of pregnancy. Semin Hematol 2013;50:222-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bánhidy F, Acs N, Puhó EH, et al. Iron deficiency anemia: pregnancy outcomes with or without iron supplementation. Nutrition 2011;27:65-72. [DOI] [PubMed] [Google Scholar]
- 4.Irani RA, Xia Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 2008;29:763-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. J Obstet Gynecol 2001;97:669. [DOI] [PubMed] [Google Scholar]
- 6.Letsky EA. Erythropoiesis in pregnancy. J Perinat Med 1995;23:39-45. [DOI] [PubMed] [Google Scholar]
- 7.Von Dadelszen P, Watson RW, Noorwali F, et al. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999;181:408-14. [DOI] [PubMed] [Google Scholar]
- 8.Chandra S, Tripathi AK, Mishra S, et al. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transf 2012;28:144-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mohamed AO, Hamza KM, Babker AM. Physiological changes in some hematological and coagulation profile among Sudanese healthy pregnant women. Int J Med Sci Public Health 2016;5:525-8. [Google Scholar]
- 10.Akingbola TS, Adewole IF, Adesina OA, et al. Haematological profile of healthy pregnant women in Ibadan, south-western Nigeria. J Obstet Gynaecol 2006;26:763-9. [DOI] [PubMed] [Google Scholar]
- 11.James TR, Reid HL, Mullings AM. Are published standards for haematological indices in pregnancy applicable across populations: an evaluation in healthy pregnant Jamaican women. BMC Pregnancy Childbirth 2008;8:8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Shen C, Jiang YM, Shi H, et al. A prospective, sequential and longitudinal study of haematological profile during normal pregnancy in Chinese women. J Obstet Gynaecol 2010;30:357-61. [DOI] [PubMed] [Google Scholar]
- 13.Purohit G, Shah T, Harsoda JM. Hematological profile of normal pregnant women in Western India. Sch J Appl Med Sci 2015;3:2195-9. [Google Scholar]
- 14.Akinbami AA, Ajibola SO, Rabiu KA, et al. Hematological profile of normal pregnant women in Lagos, Nigeria. Int J Women Health 2013;5:227-32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Abdelrahman EG, Gasim GI, Musa IR, et al. Red blood cell distribution width and iron deficiency anemia among pregnant Sudanese women. Diagn Pathol 2012;7:168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sysmex Corporation. Sysmex KX-21 N Operator’s Manual; 2006. Available from: https://www.sysmex.com/us/en/Brochures/Brochure_KX-21N_MKT-10-1023.pdf [Google Scholar]
- 17.Lee AI, Okam MM. Anemia in pregnancy. Hematol Oncol Clin North Am 2011;25:241-59, VII. [DOI] [PubMed] [Google Scholar]
- 18.Adam I, Khamis AH, Elbashir MI. Prevalence and risk factors for anaemia in pregnant women of eastern Sudan. Trans R Soc Trop Med Hyg 2005;99:739-43. [DOI] [PubMed] [Google Scholar]
- 19.Shehata HA, Ali MM, Evans-Jones JC, et al. Red cell distribution width (RDW) changes in pregnancy. Int J Gynaecol Obstet 1998;62:43-6. [DOI] [PubMed] [Google Scholar]
- 20.VanderJagt DJ, Brock HS, Melah GS, et al. Nutritional factors associated with anaemia in pregnant women in Northern Nigeria. J Health Pop Nutr 2007;25:75-81. [PMC free article] [PubMed] [Google Scholar]
- 21.Zhang Q, Li Z, Ananth CV. Prevalence and risk factors for anaemia in pregnant women: a population-based prospective cohort study in China. Paediatr Perinat Epidemiol 2009;23:282-91. [DOI] [PubMed] [Google Scholar]
- 22.Abramson N, Melton B. Leukocytosis: basics of clinical assessment. Am Fam Physician 2000;62:2053-60. [PubMed] [Google Scholar]
- 23.Kühnert M, Strohmeier R, Stegmüller M, et al. Changes in lymphocyte subsets during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1998;76:147-51. [DOI] [PubMed] [Google Scholar]
- 24.Pitkin RM, Witte DL. Platelet and leukocyte counts in pregnancy. JAMA 1979;242:2696-8. [PubMed] [Google Scholar]
- 25.Shehata N, Burrows R, Kelton JG. Gestational thrombocytopenia. Clin Obstet Gynecol 1999;42:327-34. [DOI] [PubMed] [Google Scholar]
- 26.Vagdatli E, Gounari E, Lazaridou E, et al. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 2010;14:28-32. [PMC free article] [PubMed] [Google Scholar]